Stanford is the first health care institution in Northern California
to offer patients a powerful new diagnostic imaging system known as
Positron Emission Tomography/Computerized Tomography (PET/CT) scanning.
This hybrid technology combines the strengths of two
well-established imaging modalities in one imaging session to more
accurately diagnose and locate cancers while increasing patient comfort.
Today, most PET scans are performed on instruments that are combined
PET and CT scanners. The combined PET/CT scans provide images that
pinpoint the location of abnormal metabolic activity within the body,
like malignant tumor cells. The combined scans have been shown to
provide more accurate diagnoses than the two scans performed separately.
Every PET/CT scan at Stanford is reviewed and correlated by both a
board certified nuclear medicine doctor and a board certified
radiologist at a daily joint review session. Separate full reports are
generated from each division for each patient.
The PET and CT scans are done at the same time on the same machine.
The physician is able to precisely overlay the metabolic data of the
PET scan and the detailed anatomic data of the CT scan to make a more
detailed image than either test would make by itself. A small amount
of radioactive glucose (sugar) is injected into a vein. The PET
scanner rotates around the body and makes a picture of where glucose
is being used in the body. Malignant tumor cells show up brighter in
the picture because they are more active and take up more glucose than
normal cells do. Some people are sensitive to the radioactive glucose
and may have nausea, headache, or vomiting.